EU Phase 3 trial

A multi-centre EU third phase trial required on short notice large volumes of a comparator product by AstraZeneca. CliniSped organized within a month the full quantity required in single batch with product documents.

Direct-to-Site

Clinical trial company required a facility in Europe to consolidate EU comparator products. CliniSped facilities were used and through dedicated transport, could expedite direct to multiple sites across Europe.

Multiple batch samples

CRO required samples of 8 different batches from the originator. Whilst consolidating batches onsite to reduced outgoing cold chain costs, CliniSped could fulfill the requirement through a network of EU agents